Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Favorable response of a patient with primary B/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: Case report and literature review.

Medicine - 15 Dec 2023

Wang Lixin, Pang Yanbin, Fang Chuling, Zhao Weiqiang, Xu Yuanyuan, Guo Xiao, Qiao Jingqiao, Mei Junhui, Wang Hongxin, Yu Chuan, Li Yisheng, Tang Zhixiong, Yu Li

Abstract excerpt

RATIONALE: Mixed phenotype acute leukemia (MPAL) is a rare and heterogeneous type of leukemia known for its poor prognosis. The optimal treatment strategy for this condition currently lacks consensus, leaving uncertainty in its management. Nonetheless, a potential therapeutic option for patients with refractory MPAL who express target antigens is donor-derived chimeric antigen receptor T (CAR-T) cell therapy....

Topics

Join the communities discussing this publication.

Acute Disease
Antigens, CD19
Immunotherapy, Adoptive
Leukemia, Myeloid, Acute
Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Receptors, Chimeric Antigen

Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 38115347
DOI: 10.1097/MD.0000000000036397
PMCID: PMC10727594

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Favorable response of a patient with primary B/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: Case report and literature review.PMID 38115347Read ↗

Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.Semantic proximity Read ↗

An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).Semantic proximity Read ↗

Anti-CD19 CAR T as a feasible and safe therapy for refractory/relapsed mixed phenotype acute leukemia (MPAL) patientsSemantic proximity Read ↗

Mixed-phenotype acute leukemia: historical overview and a new definition.Semantic proximity Read ↗

[A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].Semantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and PitfallsSemantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic StrategiesSemantic proximity Read ↗

Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.Semantic proximity Read ↗

Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center.Semantic proximity Read ↗

Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?Semantic proximity Read ↗

Mixed Phenotype Acute Leukemia with B/T Lineage and BCR-ABL1 Rearrangement: a Case Report and Literature Review.Semantic proximity Read ↗

Cytogenetic aberration in mixed-phenotype acute leukemia in children: A single-center retrospective review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.